Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

• Main Authors: Ernst Rüdiger Kuse, Ploenchan Chetchotisakd, Clovis Arns da Cunha, Markus Ruhnke, Carlos Barrios, Digumarti Raghunadharao, Jagdev Singh Sekhon, Antonio Freire, Venkatasubramanian Ramasubramanian, Ignace Demeyer, Marcio Nucci, Amorn Leelarasamee, Frédérique Jacobs, Johan Decruyenaere, Didier Pittet, Andrew J. Ullmann, Luis Ostrosky-Zeichner, Olivier Lortholary, Sonja Koblinger, Heike Diekmann-Berndt, Oliver A. Cornely
• Other Authors: Klinik für Viszeral- und Transplantationschirurgie
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/24872
• Institution: Mahidol University

Background: Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with liposomal amphotericin B for the treatment of adult patients with candidaemia or invasive candidosis. Methods: We did a double-blind, randomised, multinational non-inferiority...